Pathology of Hepatic Iron Overload

ABSTRACT

The role of liver biopsy in all chronic liver diseases continues to evolve with the emergence of new laboratory and imaging tests. However, the value of histologic examination for fibrosis, parenchymal architectural remodeling, and possible concurrent disease remains relatively unchallenged, including in patients with suspected iron overload. In addition, only histologic evaluation allows detailed analysis of cellular and acinar localization of iron. Routine use of an iron stain for all liver biopsy analysis enables detection of iron when not otherwise suspected.

The broad classifications of iron overload include parenchymal (“primary”) or reticuloendothelial (“secondary”), and mixed. These classifications, however, serve only as guidelines to differential diagnoses, as will be noted in the following review of pathology of iron overload. Ultimately, the role of the pathologist is to document cellular and acinar localization of iron and to provide a semiquantitative assessment of amount to alert the clinician to the possibility of a significant condition.

In this article, histopathologic findings in conditions of iron overload and in several forms of liver disease are discussed.

KEYWORDS

Hereditary hemochromatosis - HFE - parenchymal iron overload - reticuloendothelial iron

REFERENCES

• 1 Feder J N, Gnirke A, Thomas W et al.. A novel MHC class I-like gene is mutated in patients with hereditary haemochromatosis.  Nat Genet. 1996;  13 399-408
• 2 Pietrangelo A. Non-invasive assessment of hepatic iron overload: are we finally there?.  J Hepatol. 2005;  42 153-154
• 3 Bacon B R, Powell L W, Adams P C, Kresina T F, Hoofnagle J H. Molecular medicine and hemochromatosis: at the crossroads.  Gastroenterology. 1999;  116 193-207
• 4 Bacon B R. Hereditary hemochromatosis: diagnosis and management.  Gastroenterology. 2001;  120 718-725
• 5 Bacon B R, Olynyk J K, Brunt E M, Britton R S, Wolff R K. HFE genotype in patients with hemochromatosis and other liver diseases.  Ann Intern Med. 1999;  130 953-962
• 6 Bridle K R, Crawford DHG, Fletcher L M, Smith J L, Powell L W, Ramm G A. Evidence for a sub-morphological inflammatory process in the liver in haemochromatosis.  J Hepatol. 2003;  38 426-433
• 7 Hubscher S G. Iron overload, inflammation and fibrosis in genetic haemochromatosis [editorial].  J Hepatol. 2003;  38 521-525
• 8 Ramm G A, Crawford DHG, Powell L W, Walker N I, Fletcher L M, Halliday J W. Hepatic stellate cell activation in genetic haemochromatosis. Lobular distribution, effect of increasing hepatic iron and response to phlebotomy.  J Hepatol. 1997;  26 584-592
• 9 Ludwig J, Batts K P, Moyer P M, Baldus W P, Fairbanks V F. Liver biopsy diagnosis of homozygous hemochromatosis: a diagnostic algorithm.  Mayo Clin Proc. 1993;  68 263-267
• 10 Brunt E M, Olynyk J K, Britton R S, Janney C G, Di Bisceglie A M, Bacon B R. Histological evaluation of iron in liver biopsies: relationship to HFE mutations.  Am J Gastroenterol. 2000;  95 1788-1793
• 11 Turlin B, Deugnier Y. Evaluation and interpretation of iron in the liver.  Semin Diagn Pathol. 1998;  15 237-245
• 12 Bartolo C, McAndrew P E, Sosolik R C et al.. Differential diagnosis of hereditary hemochromatosis from other liver disorders by genetic analysis.  Arch Pathol Lab Med. 1998;  122 633-637
• 13 Tavill A S. Diagnosis and management of hemochromatosis.  Hepatology. 2001;  33 1321-1328
• 14 Niederau C, Fischer R, Purschel A, Stremmel W, Haussinger D, Strohmeyer G. Long-term survival in patients with hereditary hemochromatosis.  Gastroenterology. 1996;  110 1107-1119
• 15 Olynyk J K, St. Pierre T G, Britton R S, Brunt E M, Bacon B R. Duration of hepatic iron exposure increases the risk of significant fibrosis in hereditary hemochromatosis: a new role for magnetic resonance imaging.  Am J Gastroenterol. 2005;  100 837-841
• 16 Fargion S, Mattioli M, Fracanzani A L, Fiorelli G. Iron and liver diseases.  Can J Gastroenterol. 2000;  14 89D-92D
• 17 Pietrangelo A. Hemochromatosis gene modifies courses of hepatitis C viral infection.  Gastroenterology. 2003;  124 1509-1523
• 18 Fletcher L M, Dixon J L, Purdie D M, Powell L W, Crawford DHG. Excess alcohol greatly increases the prevalence of cirrhosis in hereditary hemochromatosis.  Gastroenterology. 2002;  122 281-289
• 19 Tavill A S, Qadri A M. Alcohol and iron.  Semin Liver Dis. 2004;  24 317-325
• 20 Chitturi S, George J. Interaction of iron, insulin resistance, and nonalcoholic steatohepatitis.  Curr Gastroenterol Rep. 2003;  5 18-25
• 21 Bugianesi E, Manzini P, D'Antico S et al.. Relative contribution of iron burden, HFE mutations, and insulin resistance to fibrosis in nonalcoholic fatty liver.  Hepatology. 2004;  39 179-187
• 22 Eriksson S, Lindmark B, Olsson S. Lack of association between hemochromatosis and alpha-antitrypsin deficiency.  Acta Med Scand. 1986;  219 291-294
• 23 Fargion S, Bissoli F, Fracanzani A L et al.. No association between genetic hemochromatosis and α1-antitrypsin deficiency.  Hepatology. 1996;  24 1161-1164
• 24 Elzouki A-NY, Hultcrantz R, Stal P, Befrits R, Eriksson S. Increased PiZ gene frequency for α1-antitrypsin in patients with genetic haemochromatosis.  Gut. 1995;  36 922-926
• 25 Rabinovitz M, Gavaler J S, Kelly R H, Van Thiel D H. Association between heterozygous α1-antitrypsin deficiency and genetic hemochromatosis.  Hepatology. 1992;  16 145-148
• 26 Scheuer P J, Williams R, Muir A R. Hepatic pathology in relatives of patients with haemochromatosis.  J Pathol Bacteriol. 1962;  84 53-64
• 27 Deugnier Y M, Loreal O, Turlin B et al.. Liver pathology in genetic hemochromatosis: a review of 135 homozygous cases and their bioclinical correlations.  Gastroenterology. 1992;  102 2050-2059
• 28 Diwakaran H H, Befeler A S, Britton R S, Brunt E M, Bacon B R. Accelerated hepatic fibrosis in patients with combined hereditary hemochromatosis and chronic hepatitis C infection.  J Hepatol. 2002;  36 687-691
• 29 Olynyk J K, Cullen D J, Aquilia S, Rossi E, Summerville L, Powell L W. A population-based study of the clinical expression of the hemochromatosis gene.  N Engl J Med. 1999;  341 718-724
• 30 Gochee P A, Powell L W, Cullen D J, Du Sart D, Rossi E, Olynyk J K. A population-based study of the biochemical and clinical expression of the H63D hemochromatosis mutation.  Gastroenterology. 2002;  122 646-651
• 31 Schoniger-Hekele M, Muller C, Polli C, Wrba F, Penner E, Ferenci P. Liver pathology in compound heterozygous patients for hemochromatosis mutations.  Liver. 2002;  22 295-301
• 32 Pietrangelo A. Non-HFE hemochromatosis.  Hepatology. 2004;  39 21-29
• 33 Pietrangelo A, Caleffi A, Henrion J et al.. Juvenile hemochromatosis associated with pathogenic mutations of adult hemochromatosis genes.  Gastroenterology. 2005;  128 470-479
• 34 Fleming R E, Bacon B R. Orchestration of iron homeostasis.  N Engl J Med. 2005;  352 1741-1744
• 35 Eason R J, Adams P C, Aston C E, Searle J. Familial iron overload with possible autosomal dominant inheritance.  Aust N Z J Med. 1990;  20 226-230
• 36 Morita H, Ikeda S, Yamamoto K et al.. Hereditary ceruloplasminemia deficiency with hemochromatosis: a clinicopathological study of a Japanese family.  Ann Neurol. 1995;  37 646-656
• 37 Fairbanks V F, Beutler E. Congenital atransferrinemia and idiopathic pulmonary hemosiderosis. In: Williams WJ, Beutler E, Erslev AJ Hematology. New York, NY; McGraw Hill 1983: 489-492
• 38 Kershisnik M M, Knisely A S, Sun C-CJ, Andrews J M, Wittwer C T. Cytomegalovirus infection, fetal liver disease, and neonatal hemochromatosis.  Hum Pathol. 1992;  23 1075-1080
• 39 Adams P C, Agnew S. Alcoholism in hereditary hemochromatosis revisited: prevalence and clinical consequences among homozygous siblings.  Hepatology. 1996;  23 724-727
• 40 Jakobovits A W, Morgan M Y. Hepatic siderosis in alcoholics.  Dig Dis Sci. 1979;  24 305-310
• 41 Bassett M L, Halliday J W, Powell L W. Value of hepatic iron measurements in early hemochromatosis and determination of the critical iron level associated with fibrosis.  Hepatology. 1986;  6 24-29
• 42 Brunt E M. Alcoholic and nonalcoholic steatohepatitis.  Clin Liver Dis. 2002;  6 399-420
• 43 Brunt E M. Nonalcoholic steatohepatitis: definition and pathology.  Semin Liver Dis. 2001;  21 3-16
• 44 Brunt E M, Janney C G, Di Bisceglie A M, Neuschwander-Tetri B A, Bacon B R. Nonalcoholic steatohepatitis: a proposal for grading and staging the histological lesions.  Am J Gastroenterol. 1999;  94 2467-2474
• 45 Brunt E M, Neuschwander-Tetri B A, Oliver D, Wehmeier K R, Bacon B R. Nonalcoholic steatohepatitis: histologic features and clinical correlations with 30 blinded biopsy specimens.  Hum Pathol. 2004;  35 1070-1085
• 46 Ferrannini E. Insulin resistance, iron, and the liver.  Lancet. 2000;  355 2181-2182
• 47 George D K, Goldwurm S, MacDonald G A et al.. Increased hepatic iron concentration in nonalcoholic steatohepatitis is associated with increased fibrosis.  Gastroenterology. 1998;  114 311-318
• 48 Bonkovsky H L, Zivny J, Tortorelli K, Liu Q, Lambrecht R W. Non-alcoholic steatohepatitis with iron: part of insulin resistance-associated hepatic iron overload? Reply.  J Hepatol. 2000;  33 1025-1026
• 49 Facchini F S, Hua N W, Stoohs R A. Effect of iron depletion in carbohydrate-intolerant patients with clinical evidence of nonalcoholic fatty liver disease.  Gastroenterology. 2002;  122 931-939
• 50 Angulo P, Keach J C, Batts K P, Lindor K D. Independent predictors of liver fibrosis in patients with nonalcoholic steatohepatitis.  Hepatology. 1999;  30 1356-1362
• 51 Chitturi S, Weltman M, Farrell G C et al.. HFE mutations, hepatic iron, and fibrosis: ethnic-specific association of NASH with C282Y but not with fibrotic severity.  Hepatology. 2002;  36 142-149
• 52 Bhattacharya R, Kowdley K V. Iron and HFE mutations in nonalcoholic steatohepatitis: innocent bystanders or accessories to the crime?.  Gastroenterology. 2003;  125 615-616
• 53 Yamauchi N, Itoh Y, Tanaka Y et al.. Clinical characteristics and prevalence of GB virus C, SEN virus, and HFE gene mutation in Japanese patients with nonalcoholic steatohepatitis.  J Gastroenterol. 2004;  39 654-660
• 54 Mendler M H, Turlin B, Moirand R et al.. Insulin resistance-associated hepatic iron overload.  Gastroenterology. 1999;  117 1155-1163
• 55 Turlin B, Mendler M-H, Moirand R, Guyader D, Guillygomarc'h A, Deugnier Y. Histologic features of the liver in insulin resistance-associated iron overload. A study of 139 patients.  Am J Clin Path. 2001;  116 263-270
• 56 Bardadin K A, Scheuer P J. Endothelial cell changes in acute hepatitis: a light and electron microscopic study.  J Pathol. 1984;  144 213-220
• 57 Ishak K G. Light microscopic morphology of viral hepatitis.  Am J Clin Pathol. 1976;  65(5 Suppl) 787-827
• 58 Hengeveld P, Zuyderhoudt F M, Jobsis A C, van Gool J. Some aspects of iron metabolism during acute viral hepatitis.  Hepatogastroenterology. 1982;  29 138-141
• 59 Kaji K, Nakanuma Y, Sasaki M, Unoura M, Kobayashi K-I, Nonomura A. Hemosiderin deposition in portal endothelial cells: a novel hepatic hemosiderosis frequent in chronic viral hepatitis B and C.  Hum Pathol. 1995;  26 1080-1085
• 60 Barton A L, Banner B F, Cable E E, Bonkovsky H. Distribution of iron in the liver predicts the response of chronic hepatitis C infection to interferon therapy.  Am J Clin Pathol. 1995;  103 419-424
• 61 Pianko S, McHutchison J G, Gordon S C et al.. Hepatic iron concentration does not influence response to therapy with interferon plus ribavirin in chronic HCV infection.  J Interferon Cytokine Res. 2002;  22 483-489
• 62 Bonkovsky H, Banner B F, Rothman A L. Iron and chronic viral hepatitis.  Hepatology. 1997;  25 759-768
• 63 Lefkowitch J H, Yee H T, Sweeting J, Green PHR, Magun A M. Iron-rich foci in chronic viral hepatitis.  Hum Pathol. 1998;  29 116-118
• 64 Fiel M I, Schiano T D, Guido M et al.. Increased hepatic iron deposition resulting from treatment of chronic hepatitis C with ribavirin.  Am J Clin Path. 2000;  113 35-39
• 65 Scheuer P J, Lefkowitch J H. Disturbances of copper and iron metabolism. In: Scheuer PJ, Lefkowitch JH Liver Biopsy Interpretation. London, UK; WB Saunders 2000: 275-283
• 66 Brunt E M, Tavill A S, Bacon B R. A 49-year-old man with a1-antitrypsin deficiency and abnormal iron study results.  Semin Liver Dis. 1996;  16 97-101
• 67 Graziadei I W, Joseph J J, Wiesner R H, Therneau T M, Batts K P, Porayko M K. Increased risk of chronic liver failure in adults with heterozygous a1-antitrypsin deficiency.  Hepatology. 1998;  28 1058-1063
• 68 Ludwig J, Hashimoto E, Porayko M K, Moyer T P, Baldus W P. Hemosiderosis in cirrhosis: a study of 447 native livers.  Gastroenterology. 1997;  112 882-888
• 69 Deugnier Y, Turlin B, Le Quilleuc D et al.. A reappraisal of hepatic siderosis in patients with end-stage cirrhosis: practical implications for the diagnosis of hemochromatosis.  Am J Surg Pathol. 1997;  21 669-675
• 70 Deugnier Y M, Guyader D, Crantock L et al.. Primary liver cancer in genetic hemochromatosis: a clinical, pathological and pathogenetic study of 54 cases.  Gastroenterology. 1993;  104 228-234
• 71 Deugnier Y M, Charalambous P, Le Quilleuc D et al.. Preneoplastic significance of hepatic iron-free foci in genetic hemochromatosis: a study of 185 patients.  Hepatology. 1993;  18 1363-1369
• 72 Blumberg R S, Chopra S, Ibrahim R et al.. Primary hepatocellular carcinoma in idiopathic hemochromatosis after reversal of cirrhosis.  Gastroenterology. 1988;  95 1399-1402
• 73 Bottomley S S. Secondary iron overload disorders.  Semin Hematol. 1998;  35 77-86
• 74 Gordeuk V, Mukabi J, Hasstedt J et al.. Iron overload in Africa: interaction between a gene and dietary iron content.  N Engl J Med. 1992;  326 95-100
• 75 Mandishona E, MacPhail A P, Gordeuk V R et al.. Dietary iron overload as a risk factor for hepatocellular carcinoma in black Africans.  Hepatology. 1998;  27 1563-1566
• 76 Andrews N C. Disorders of iron metabolism.  N Engl J Med. 1999;  341 1986-1995
• 77 Wurapa R K, Gordeuk V R, Brittenham G M, Khiyami A, Schechter G P, Edwards C Q. Primary iron overload in African Americans.  Am J Med. 1996;  101 9-18
• 78 Barton J C, Edwards C Q, Bertoli L F, Shroyer T W, Hudson S L. Iron overload in African Americans.  Am J Med. 1995;  99 616-623
• 79 Brown K E, Khan C M, Zimmerman B, Brunt E M. Hepatic iron overload in blacks and whites: a comparative autopsy study.  Am J Gastroenterol. 2003;  98 1594-1598
• 80 Sindram J W, Marx JJM. Localization of iron in the hepatic acini and the bile duct epithelium as a tool for estimation of liver iron overload.  Ann NY Acad Sci. 1988;  526 361-362
• 81 Rowe J W, Wands J R, Mezey E et al.. Familial hemochromatosis: characteristics of the precirrhotic stage in a large kindred.  Medicine. 1977;  56 197-211
• 82 Searle J, Leggett B A, Crawford DHG, Powell L W. Iron storage diseases. In: MacSween RNM, Anthony PP, Scheuer PJ, Portmann BC, Burt AD, Ishak KG Pathology of the Liver. London, UK; Churchill Livingstone 2002: 257-272
• 83 Brissot P, Bourel M, Herry D et al.. Assessment of liver iron content in 271 patients: a reevaluation of direct and indirect methods.  Gastroenterology. 1981;  80 557-565
• 84 Olynyk J, Hall P, Sallie R, Reed W, Shilkin K, Mackinnon M. Computerized measurement of iron in liver biopsies: a comparison with biochemical iron measurement.  Hepatology. 1990;  12 26-30